Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS

Clinical Chemistry

Volumn 55, Issue 7, 2009, Pages 1395-1405

  Helander, Anders ^a,b   Zheng, Yufang ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; FATTY ACID; LIPID; PHOSPHATIDYLETHANOL; PHOSPHATIDYLPROPANOL; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; ELECTROSPRAY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCEROPHOSPHOLIPIDS; HUMANS; REFERENCE STANDARDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 67650081281     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.120923     Document Type: Article

References (37)

1. Helander A. Biological markers in alcoholism. J Neural Transm Suppl 2003;(66):15-32.
2. Schmitt G, Aderjan R, Keller T, Wu M. Ethyl glucuronide: an unusual ethanol metabolite in humans. Synthesis, analytical data, and determination in serum and urine. J Anal Toxicol 1995;19:91-4.
3. Helander A, Beck O. Mass spectrometric identification of ethyl sulfate as an ethanol metabolite in humans. Clin Chem 2004;50:936-7.
4. Best CA, Laposata M. Fatty acid ethyl esters: toxic non-oxidative metabolites of ethanol and markers of ethanol intake. Front Biosci 2003;8:e202-17.
5. Erim Y, Böttcher M, Dahmen U, Beck O, Broelsch CE, Helander A. Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation. Liver Transpl 2007;13:757-61.
6. Politi L, Leone F, Morini L, Polettini A. Bioanalytical procedures for determination of conjugates or fatty acid esters of ethanol as markers of ethanol consumption: a review. Anal Biochem 2007;368:1-16.
7. Helander A, Böttcher M, Fehr C, Dahmen N, Beck O. Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcohol 2009;44:55-61.
8. Jeppsson JO, Arndt T, Schellenberg F, Wielders JP, Anton RF, Whitfield JB, Helander A. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med 2007;45:558-62.
9. Bergström JP, Helander A. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta 2008;388:59-67.
10. Alling C, Gustavsson L, Änggård E. An abnormal phospholipid in rat organs after ethanol treatment. FEBS Lett 1983;152:24-8.
11. Yang SF, Freer S, Benson AA. Transphosphatidylation by phospholipase D. J Biol Chem 1967;242:477-84.
12. Gustavsson L. Phosphatidylethanol formation: specific effects of ethanol mediated via phospholipase D. Alcohol Alcohol 1995;30:391-406.
13. Kobayashi M, Kanfer JN. Phosphatidylethanol formation via transphosphatidylation by rat brain synaptosomal phospholipase D. J Neurochem 1987;48:1597-603.
14. Chalifa-Caspi V, Eli Y, Liscovitch M. Kinetic analysis in mixed micelles of partially purified rat brain phospholipase D activity and its activation by phosphatidylinositol 4,5-bisphosphate. Neurochem Res 1998;23:589-99.
15. Varga A, Hansson P, Lundqvist C, Alling C. Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers. Alcohol Clin Exp Res 1998;22:1832-7.
16. Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C. Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol 2006;41:431-7.
17. Hansson P, Caron M, Johnson G, Gustavsson L, Alling C. Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal. Alcohol Clin Exp Res 1997;21:108-10.
18. Gunnarsson T, Karlsson A, Hansson P, Johnson G, Alling C, Odham G. Determination of phosphatidylethanol in blood from alcoholic males using high-performance liquid chromatography and evaporative light scattering or electrospray mass spectrometric detection. J Chromatogr B Biomed Sci Appl 1998;705:243-9.
19. Varga A, Hansson P, Johnson G, Alling C. Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta 2000;299:141-50.
20. Aradottir S, Olsson BL. Methodological modifications on quantification of phosphatidylethanol in blood from humans abusing alcohol, using highperformance liquid chromatography and evaporative light scattering detection. BMC Biochem 2005;6:18.
21. Varga A, Nilsson S. Nonaqueous capillary electrophoresis for analysis of the ethanol consumption biomarker phosphatidylethanol. Electrophoresis 2008;29:1667-71.
22. Nissinen AE, Makela SM, Vuoristo JT, Liisanantti MK, Hannuksela ML, Horkko S, Savolainen MJ. Immunological detection of in vitro formed phosphatidylethanol - an alcohol biomarker - with monoclonal antibodies. Alcohol Clin Exp Res 2008;32:921-8.
23. Holbrook PG, Pannell LK, Murata Y, Daly JW. Molecular species analysis of a product of phospholipase D activation: phosphatidylethanol is formed from phosphatidylcholine in phorbol ester- and bradykinin-stimulated PC12 cells. J Biol Chem 1992;267:16834-40.
24. Houjou T, Yamatani K, Imagawa M, Shimizu T, Taguchi R. A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 2005;19:654-66.
25. Connor WE, Lin DS, Thomas G, Ey F, DeLoughery T, Zhu N. Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia. J Lipid Res 1997;38:2516-28.
26. Ekroos K, Ejsing CS, Bahr U, Karas M, Simons K, Shevchenko A. Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation. J Lipid Res 2003;44:2181-92.
27. Leidl K, Liebisch G, Richter D, Schmitz G. Mass spectrometric analysis of lipid species of human circulating blood cells. Biochim Biophys Acta 2008;1781:655-64.
28. Tolonen A, Lehto TM, Hannuksela ML, Savolainen MJ. A method for determination of phosphatidylethanol from high density lipoproteins by reversed-phase HPLC with TOF-MS detection. Anal Biochem 2005;341:83-8.
29. Radin NS. Extraction of tissue lipids with a solvent of low toxicity. Methods Enzymol 1981;72:5-7.
30. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003;49:1041-4.
31. Beermann C, Mobius M, Winterling N, Schmitt JJ, Boehm G. sn-Position determination of phospholipid-linked fatty acids derived from erythrocytes by liquid chromatography electrospray ionization ion-trap mass spectrometry. Lipids 2005;40:211-8.
32. Aradottir S, Moller K, Alling C. Phosphatidylethanol formation and degradation in human and rat blood. Alcohol Alcohol 2004;39:8-13.
33. Aradottir S, Seidl S, Wurst FM, Jönsson BA, Alling C. Phosphatidylethanol in human organs and blood: a study on autopsy material and influences by storage conditions. Alcohol Clin Exp Res 2004;28:1718-23.
34. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008;47:348-80.
35. Rivier L. Criteria for the identification of compounds by liquid chromatography-mass spectrometry and liquid chromatography-multiple mass spectrometry in forensic toxicology and doping analysis. Anal Chim Acta 2003;492:69-82.
36. Kugelberg FC, Jones AW. Interpreting results of ethanol analysis in postmortem specimens: a review of the literature. Forensic Sci Int 2007;165:10-29.
37. O'Neal CL, Poklis A. Postmortem production of ethanol and factors that influence interpretation. Am J Forens Med Pathol 1996;17:8-20.